“…Individuals who are at highest risk for overdose, such as those who have overdosed or those who recently were treated in a withdrawal management program (colloquially referred to as âdetoxâ), do not typically access MOUD ( Larochelle et al, 2018 ; Walley et al, 2020 ). Specific factors that further elevate the risk of overdose among those using opioids include: 1) having had a prior opioid overdose ( Caudarella et al, 2016 ; Darke et al, 2011 ; Larochelle et al, 2018 ; Larochelle et al, 2019 ; Winhusen et al, 2016 ); 2) having reduced opioid tolerance (e.g., completing medically supervised or âsociallyâ managed withdrawal, or release from an institutional setting such as jail, residential treatment, hospital) ( Binswanger et al, 2007 ; Larochelle et al, 2019 ; Merrall et al, 2010 ; Strang et al, 2003 ; Walley et al, 2020 ); 3) using other substances (e.g., alcohol, benzodiazepines, stimulants) ( Brugal et al, 2002 ; Cho et al, 2020 ; Gladden et al, 2019 ; Larochelle et al, 2019 ; Park et al, 2020 ; Park et al, 2015 ; Sun et al, 2017 ); 4) having a concomitant major mental illness (e.g., major depression, bipolar disorder, schizophrenia, anxiety disorders) ( OâDriscoll et al, 2001 ; Pabayo et al, 2013 ; Tobin and Latkin, 2003 ; Wines et al, 2007 ); 5) having a concomitant major medical illness (e.g., cirrhosis, chronic kidney disease, COPD, asthma, sleep apnea, congestive heart failure; infections related to drug use) ( Bosilkovska et al, 2012 ; Green et al, 2012 ; Jolley et al, 2015 ; Larochelle et al, 2019 ; Vu et al, 2018 ); and/or 6) injecting drugs ( Bazazi et al, 2015 ; Brugal et al, 2002 ).…”